Product Information
COPAXONE 20 MG/ML SYRINGE is a brand product labeled by Teva Neuroscience, Inc., priced at $229.7988 per ML under NDC 68546031730. Its NADAC has been published 568 times since Nov 28, 2013.
FDA first approved this application on Dec 20, 1996. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the Glatiramer Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/mL
Manufacturer
Teva Neuroscience, Inc.NDC
68546031730
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
GLATIRAMER ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA020622FDA Approved
12/20/1996
TE Code
AP
On Market Since
4/28/2008
Price Statistics
The NADAC for COPAXONE 20 MG/ML SYRINGE has been published 568 times since Nov 28, 2013, and over the history we have for it it has declined 94.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $229.7988 per ML |
|---|---|
| All-time high | $5406.0222 (Sep 24, 2014) |
| All-time low | $178.6547 (Dec 17, 2014) |
| 52-week high | $230.1972 |
| 52-week low | $228.9944 |
| Median price | $230.0026 |
| Average price | $586.5204 |
| Largest weekly change | -96.7% (Nov 19, 2014) |
| Weeks tracked | 568 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Neuroscience, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glatiramer Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COPAXONE 20 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for COPAXONE 20 MG/ML SYRINGE, manufactured by Teva Neuroscience, Inc., is $229.7988 per ML (NDC 68546031730), effective Sep 30, 2026.
How has the price of COPAXONE 20 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for COPAXONE 20 MG/ML SYRINGE has declined 94.9%. It has been tracked across 568 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for COPAXONE 20 MG/ML SYRINGE?
Since Nov 28, 2013, the NADAC for COPAXONE 20 MG/ML SYRINGE has ranged from a low of $178.6547 (Dec 17, 2014) to a high of $5406.0222 (Sep 24, 2014), with a median of $230.0026 per ML.
Are there cheaper alternatives to COPAXONE 20 MG/ML SYRINGE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLATOPA 20 MG/ML SYRINGE, is $41.7570 per ML — about 82% below COPAXONE 20 MG/ML SYRINGE.
Who manufactures COPAXONE 20 MG/ML SYRINGE?
COPAXONE 20 MG/ML SYRINGE (NDC 68546031730) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.